Sartorius Aktiengesellschaft (0NIQ)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 209.00 |
|---|---|
| 52-week range | 157.52 – 215.50 |
| Return, 1 month / 3 months | +2.2% / +20.0% |
| Return, 1 year / 3 years | +8.2% / −3.4% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 41.0% |
| Worst drawdown (1 year) | -21.1% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sartorius Aktiengesellschaft is a German supplier of laboratory and process equipment for the life sciences and biopharmaceutical industries. Its laboratory products include balances, pipettes and water purification systems used in research and quality control, while its process solutions cover filtration, fermentation and fluid management equipment for drug manufacturing. Customers include pharmaceutical companies, contract manufacturers and academic and industrial laboratories. The company is headquartered in Göttingen, Germany, and operates through laboratory and bioprocess solutions divisions serving markets around the world.
On this site Sartorius Aktiengesellschaft appears as a stock on the London Exchange (UK), code 0NIQ, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sartorius Aktiengesellschaft (0NIQ) trades on the London Exchange in UK. It last closed at EUR 209.00 on 21 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,400 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.2% and over the last three months it rose 20.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.9% | ||
| From 52-week high | -3.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.0% | ||
| 6-month return | 21.2% | ||
| 12-month return, skipping the last month | 5.9% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.1% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 8.3% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +2.2% |
| 3 months | +20.0% |
| 6 months | +21.2% |
| 1 year | +8.2% |
| 3 years | −3.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 198.14 / 186.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.55 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | EUR 0.7300 |
| 28 Mar 2025 | EUR 0.7300 |
| 2 Apr 2024 | EUR 0.7300 |
| 30 Mar 2023 | EUR 1.4300 |
| 28 Mar 2022 | EUR 1.2500 |
| 29 Mar 2021 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.